TY - JOUR
T1 - Halogen Bonds in Ligand-Protein Systems
T2 - Molecular Orbital Theory for Drug Design
AU - Margiotta, Enrico
AU - van der Lubbe, Stephanie C.C.
AU - de Azevedo Santos, Lucas
AU - Paragi, Gabor
AU - Moro, Stefano
AU - Bickelhaupt, F. Matthias
AU - Fonseca Guerra, Célia
PY - 2020/3/23
Y1 - 2020/3/23
N2 - Halogen bonds are highly important in medicinal chemistry as halogenation of drugs, generally, improves both selectivity and efficacy toward protein active sites. However, accurate modeling of halogen bond interactions remains a challenge, since a thorough theoretical investigation of the bonding mechanism, focusing on the realistic complexity of drug-receptor systems, is lacking. Our systematic quantum-chemical study on ligand/peptide-like systems reveals that halogen bonding is driven by the same bonding interactions as hydrogen bonding. Besides the electrostatic and the dispersion interactions, our bonding analyses, based on quantitative Kohn-Sham molecular orbital theory together with energy decomposition analysis, reveal that donor-acceptor interactions and steric repulsion between the occupied orbitals of the halogenated ligand and the protein need to be considered more carefully within the drug design process.
AB - Halogen bonds are highly important in medicinal chemistry as halogenation of drugs, generally, improves both selectivity and efficacy toward protein active sites. However, accurate modeling of halogen bond interactions remains a challenge, since a thorough theoretical investigation of the bonding mechanism, focusing on the realistic complexity of drug-receptor systems, is lacking. Our systematic quantum-chemical study on ligand/peptide-like systems reveals that halogen bonding is driven by the same bonding interactions as hydrogen bonding. Besides the electrostatic and the dispersion interactions, our bonding analyses, based on quantitative Kohn-Sham molecular orbital theory together with energy decomposition analysis, reveal that donor-acceptor interactions and steric repulsion between the occupied orbitals of the halogenated ligand and the protein need to be considered more carefully within the drug design process.
UR - http://www.scopus.com/inward/record.url?scp=85082146262&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082146262&partnerID=8YFLogxK
U2 - 10.1021/acs.jcim.9b00946
DO - 10.1021/acs.jcim.9b00946
M3 - Article
C2 - 32003997
SN - 1549-9596
VL - 60
SP - 1317
EP - 1328
JO - Journal of Chemical Information and Modeling
JF - Journal of Chemical Information and Modeling
IS - 3
ER -